Morgellons Symptoms: Lesions, Fibers & Skin Sensations

Morgellons may first be experienced as a sensation no one else can see, a lesion that keeps reopening, or a filament that seems out of place. The difficulty is not a shortage of observations. It is that three different questions—what a person feels, what can be observed, and what may explain it—are often collapsed into one.

That collapse can lead in opposite directions. A physical finding may be dismissed before it is examined, or an unusual observation may be treated as proof of a cause it cannot establish. This guide keeps the questions separate while taking all three seriously.

Reported experienceSymptomsWhat a person feels: itching, burning, crawling, fatigue, pain, or brain fog.
Documentable findingObservable signsWhat can be examined: a lesion, follicular plug, crust, filament, or secondary infection.
Proposed meaningInterpretationsPossible explanations involving inflammation, neuropathy, infection, contamination, manipulation, delusional infestation, or another process.

Keeping those levels separate makes a medical evaluation more—not less—open-minded. It prevents an unusual symptom from being dismissed without examination while also preventing an observation from being stretched into a diagnosis it cannot establish.

The short version: The most characteristic Morgellons presentation combines a fiber or material complaint with lesions and/or disturbing skin sensations. The useful next step is to document the location and sequence of events, protect the skin from further injury, and have the least-manipulated finding examined in context.

Morgellons Symptoms at a Glance

Reported featureWhat it may documentWhat it cannot establish by itself
Itching, crawling, stinging, burning, or pins-and-needles sensationsA genuine sensory symptom requiring evaluationParasites, fibers moving, infection, or delusional infestation
Slow-healing, recurrent, or painful lesionsA skin or wound problem that may need treatmentOne specific cause or a Morgellons diagnosis
Fibers beneath, embedded in, or projecting from skinA potentially tissue-associated structure worth documenting carefullyComposition, biological origin, or infectious cause
Loose fibers on an open lesionMaterial is present that may have come from the environment and adhered to the siteThat the body produced the material
Follicular plugs, casts, or comedo-like materialA follicular structure that can be examined and compared with known conditionsThat it is unique to Morgellons or responsible for sensation
Fatigue, sleep problems, cognitive complaints, or musculoskeletal painClinically important symptoms that affect function and quality of lifeThat Morgellons caused them or that they identify a particular infection

One Name, Different Symptom Patterns

Morgellons remains disputed partly because studies have not used one consistent case definition. A 2025 review found no standardized diagnostic framework or biomarker and called for consensus criteria, multicenter observational studies, and defined outcome measures before high-quality treatment trials can be conducted.[1]

The largest CDC-supported investigation used a broad case definition: self-reported fibers or other solid material coming from the skin accompanied by a lesion and/or a disturbing skin sensation.[2] Smaller filament-focused studies have commonly selected patients after microscopic fibers were reported beneath unbroken skin or associated with lesions. Those approaches do not necessarily assemble the same patient population.

This means two people using the word Morgellons may be describing substantially different presentations. One may have an intact-skin filament observed under magnification. Another may have ordinary fibers adhering to a chronic wound. A third may have severe crawling sensations without a visible primary lesion. A fourth may have a recognized follicular disorder together with an incorrect explanation for it.

The label should not replace the work of identifying which features are present in the individual patient.

Skin Findings Reported With Morgellons

Slow-healing or recurrent lesions

Patients frequently describe lesions that heal slowly, reopen, recur in the same area, or appear in multiple locations. Depending on the person and stage of the lesion, the visible finding may be described as a papule, erosion, ulcer, crust, nodule, excoriation, discolored area, or scar.

Those words describe appearance—not cause. A lesion can be altered by time, scratching, squeezing, adhesives, topical products, infection, and repeated removal of crust or plugs. By the time it is examined, the original lesion may no longer be visible.

That chronology matters. A primary lesion that appeared before manipulation carries different information from an ulcer photographed after repeated attempts to remove material. Taking manipulation seriously does not mean assuming the patient created the original symptom. It means preserving the sequence needed to distinguish what came first.

For practical lesion care and the limits of experimental claims, see Morgellons Lesion Treatment: What the Evidence Says.

Craters, plugs, and cup-shaped depressions

Some patients describe a central plug seated within a crater or an indentation remaining after material is removed. These observations deserve more precise documentation than the general word sore. Useful details include whether the lesion was naturally umbilicated, whether a plug was visible before touching it, whether the structure was centered on a follicle, and what the surrounding skin looked like.

Plug-centered lesions are not unique to Morgellons. Keratin plugs, comedones, ingrown hairs, folliculitis, trichostasis spinulosa, and acquired perforating disorders can produce superficially similar forms. Their relevance lies in giving a clinician a defined structure to examine—not in supplying a diagnosis from appearance alone.

The comparison with reactive perforating collagenosis and acquired perforating dermatosis is developed in Reactive Perforating Collagenosis vs. Morgellons: The Stain That Would Settle It.

Fibers or filaments associated with skin

The word fiber covers observations with very different evidentiary value. A loose thread found on clothing or resting on skin is not equivalent to a filament photographed beneath an apparently intact surface, projecting from a follicle or preserved within a biopsy.

Color does not resolve the difference. White, blue, red, and black material can be biological, environmental, or artifactual, and lighting or digital processing can change its appearance. The more useful questions concern location, attachment, scale, contamination control, and tissue relationship.

Small studies led by Marianne Middelveen and Raphael Stricker have reported keratin and collagen in selected tissue-associated filaments.[3][4] A search of the published literature through September 2026 identified no comparable independent laboratory replication of those findings. The CDC paper’s abstract summarizes the material it collected as mostly cellulose, likely cotton. The detailed results are more granular: 23 non-biopsy specimens from 12 participants were analyzed; 83% contained protein, described as likely superficial skin, and 43% contained cellulose consistent with cotton. The categories overlapped, and some samples contained other materials.[2] These studies asked different specimen questions, which is why collection conditions and tissue context matter.

See Morgellons Fibers: What the Research Shows for the full evidence review.

Follicular casts and comedo-like material

Patients sometimes describe translucent sleeves, hardened material, retained hairs, black specks, or tapered structures associated with a pore. A 2013 primary study examined removed, non-biopsy specimens that the authors called calluses and reported protruding keratin projections on their concave undersides. A 2018 review by Middelveen, Fesler, and Stricker reinterpreted those projections as thickened follicular casts and also discussed comedo-like masses.[3][4] These observations come from overlapping author teams, and no comparable independent replication was identified in literature reviewed through September 2026.

These structures have not been established as unique to Morgellons. Ordinary hair casts, keratin plugs, comedones, ingrown hairs, inflammatory debris, and bundles of retained vellus hairs can resemble some patient descriptions. An extracted object also loses the orientation and tissue relationship needed to determine where it was located.

For that reason, the intact follicle is more informative than the object after removal. A focused analysis explains why in Morgellons Follicular Casts and Skin Sensations.

Secondary infection, inflammation, and scarring

Any chronic or repeatedly opened lesion can develop secondary problems. Increasing redness, warmth, swelling, drainage, pain, or fever may indicate infection and should be evaluated independently of the Morgellons controversy. Post-inflammatory color change and scarring can remain after the active process has improved.

Treating a secondary infection or inflammatory disorder does not settle what began the episode. It addresses a current medical problem that can worsen if ignored.

Crawling, Burning, Stinging, and Other Skin Sensations

Reported Morgellons sensations include:

  • Itching or intense pruritus
  • Crawling on or beneath the skin, sometimes called formication
  • Stinging or biting sensations
  • Burning
  • Pins-and-needles, prickling, or tingling
  • Pressure or a foreign-body sensation
  • Splinter-like pain localized to a pore or lesion
  • Tenderness or pain around a wound

These sensations can be severe even when a skin finding is small or temporarily invisible. Inflammation, altered itch processing, peripheral neuropathy, a follicular process, medication effects, and repeated injury are among the categories a clinician may need to consider.

A crawling sensation is not the same as delusional infestation. That diagnosis concerns a fixed false belief, not the mere presence of itching, formication, a specimen, or an unusual description. The sensory experience and the explanation assigned to it require separate evaluation.

Read Morgellons or Delusional Infestation? The Difference Must Be Investigated for a fuller discussion of this distinction.

Which usually comes first: sensation, lesion, or material?

No single order has been established. In the CDC-supported study, 70 of 115 people completed the symptom survey. Among those respondents, 57% reported disturbing skin sensations as the first manifestation, 16% reported lesions first, 10% reported solid material first, and 13% said the three categories began together.[2] Those published percentages total 96%; the remaining 4%, about three respondents, is not accounted for in the article.

These are self-reported sequences from a broad case definition, not proof of one disease pathway. Their practical value is showing why chronology should be recorded rather than reconstructed after a lesion has changed.

What appeared first?Self-reported sequence among 70 survey respondents in the CDC-supported study
Disturbing skin sensations
57%
Lesions
16%
Solid material
10%
All three together
13%
Not accounted for
4%

Important: The published percentages total 96%; the article does not account for the remaining 4%. These values describe participant recall, not a disease pathway.

Source: Pearson et al., PLOS ONE (2012).

Fatigue, Sleep, Cognitive, and Musculoskeletal Symptoms

People identifying with Morgellons frequently report problems beyond the skin, including:

  • Persistent fatigue
  • Poor or disrupted sleep
  • Difficulty concentrating or short-term memory complaints
  • Muscle or joint pain
  • Headache
  • Numbness, tingling, or other neuropathic symptoms
  • Anxiety, depressed mood, social withdrawal, or distress

Fatigue, poor sleep, pain, depression, and cognitive complaints can reinforce one another and occur with many infectious, inflammatory, endocrine, neurologic, medication-related, and psychiatric conditions. They deserve ordinary clinical evaluation rather than automatic assignment to—or exclusion from—the Morgellons label.

The burden should not be minimized simply because causation is uncertain. In a 2025 British Journal of Dermatology study, 50 patients diagnosed with Morgellons who had not yet been treated completed quality-of-life surveys at an academic dermatology clinic. Mean scores were compared with values from previously published studies—not with concurrently enrolled controls—and indicated substantial effects on dermatology-related quality of life and sleep. Eighty-four percent had a documented psychiatric history, but the cross-sectional study could not establish which conditions came first or whether one caused another.[5]

Who Reports Morgellons Symptoms?

Morgellons symptoms have been reported by people of different ages and sexes. The best population-based estimate comes from the CDC-supported Kaiser Permanente Northern California study, which used electronic health records and a broad symptom-and-material case definition. It identified 3.65 cases per 100,000 enrollees; the rate was highest among people ages 45–64, and 77% of identified participants were women and 77% were White.[2]

3.65identified cases per 100,000 enrollees
45–64age range with the highest observed rate
77% / 77%women / White participants identified

Those figures describe one insured Northern California population from 2006–2008, not everyone with Morgellons symptoms. They may reflect the study definition, access to care, recognition, and who sought help, so they should not be treated as a universal risk profile.

Two Studies, Two Very Different Cohorts

Percentages from different studies cannot be combined as though they came from one population. The two frequently cited cohorts below used different selection methods and therefore answer different questions.

CDC-supported cohortStarted with a broad, self-reported complaint involving material plus a lesion and/or disturbing skin sensation.115 people identified · 70 completed the survey
2018 Lyme-practice cohortStarted with patients reported as Lyme-seropositive and required microscopic fibers in lesions or beneath unbroken skin.60 patients · one specialty practice

The CDC-supported unexplained-dermopathy cohort

The 2012 investigation identified 115 people using a broad, self-reported case definition. Seventy completed the cross-sectional survey. Among those respondents, 71% reported muscle aches, and 70% reported fatigue lasting at least six months.[2]

Forty-one participants received a clinical evaluation. Of 37 biopsies taken from lesions, 19 (51%) showed solar elastosis, 15 of 37 (about 40%) showed excoriation or chronic irritation, and six (16%) had features consistent with an arthropod bite or drug allergy; more than one finding could occur in a specimen. Biopsies from clinically normal skin were essentially normal, and no common infection was identified.[2]

What did lesion biopsies show?Findings reported in 37 biopsies from the CDC-supported cohort
Solar elastosisSun-related tissue change
19/37 · 51%
Excoriation or chronic irritationChanges compatible with repeated injury
15/37 · 41%
Arthropod bite or drug allergyFeatures considered consistent with either
6/37 · 16%

These categories can overlap. They are not pieces of a 100% total, and they do not identify one shared cause.

Source: Pearson et al., PLOS ONE (2012).

The investigators also reported cognitive impairment in at least one tested domain for 23 of 39 participants (59%), a clinically significant elevation on at least one Personality Assessment Inventory domain for 25 of 40 (63%), and at least one drug detected in hair samples for 20 of 40 (50%). The study lacked a comparison group and could not determine whether detected drugs contributed to symptoms, were used in response to symptoms, or were unrelated. These findings belong in the account alongside the study’s quality-of-life and specimen results.[2]

For a denominator-by-denominator analysis, see The CDC Morgellons Study: What It Found—and What It Couldn’t Prove.

A selected Lyme-practice cohort

A 2018 study evaluated 60 patients drawn from a single San Francisco practice specializing in tick-borne disease. The authors—Fesler, Middelveen, and Stricker—have published extensively in support of the hypothesis that Morgellons is associated with Borrelia infection. All 60 patients were reported as Lyme-seropositive, and Morgellons classification required fibers seen in lesions or beneath unbroken skin with a handheld microscope.[6]

Lyme and coinfection testing was performed through IGeneX, a CLIA-certified specialty laboratory, with repeat testing required. The paper says seropositivity used “standard laboratory interpretation criteria” described in an earlier publication; it does not say that every patient met the CDC-recommended two-tier testing criteria.[6]

Within that selected cohort:

Reported condition or symptomPatientsPercentage
Musculoskeletal symptoms56 of 6093%
Fatigue53 of 6088%
Insomnia48 of 6080%
Cognitive impairment30 of 6050%
Depression30 of 6050%
Anxiety20 of 6033%
Neuropathy20 of 6033%

These figures describe a highly selected group of Lyme-seropositive patients from one specialty practice. They are not prevalence estimates for everyone who reports Morgellons symptoms.

Why the difference matters

The CDC-supported study began with a broad symptom-and-material complaint. The 2018 study began with Lyme-seropositive patients in a specialty practice and required microscopic filament findings. Different entry criteria can produce different symptom frequencies.

Before comparing studies, ask:

  • Who was eligible?
  • Was the finding self-reported or observed?
  • Was intact skin examined before manipulation?
  • How many participants completed each part of the study?
  • Was there a comparison group?
  • Can the design establish association, frequency, or cause?

Take the Morgellons Survey to help document patient-reported symptom patterns, history, and lived experience. The survey does not diagnose Morgellons or replace medical care.

What Else Could Produce These Symptoms?

A responsible evaluation does not begin by choosing between “Morgellons” and “delusion.” It begins by asking which recognized conditions could account for each observed feature.

Depending on the presentation, a clinician may consider:

  • Eczema, contact dermatitis, psoriasis, or another inflammatory dermatosis
  • Folliculitis, acneiform conditions, ingrown hairs, or trichostasis spinulosa
  • Bacterial, fungal, viral, or parasitic infection when supported by examination or testing
  • Arthropod bites or environmental exposures
  • Chronic pruritus related to liver, kidney, thyroid, hematologic, or metabolic disease
  • Peripheral neuropathy or another neurologic cause of burning, tingling, or formication
  • Medication adverse effects, substance exposure, or withdrawal
  • Compulsive skin picking or manipulation that perpetuates injury
  • Delusional infestation when a fixed false belief is established after appropriate evaluation
  • More than one condition occurring at the same time

Finding a recognized diagnosis is not a failure to take the patient seriously. It may provide a treatable explanation. Likewise, an initial nondiagnostic examination does not erase prior observations. The goal is to replace broad labels with findings that can be documented, tested, and treated.

What Morgellons Symptoms Do Not Prove

Symptoms or photographs alone do not prove that:

  • A parasite, insect, or organism is living beneath the skin
  • Fibers are moving independently
  • The material is fungal, synthetic, or technological
  • Borrelia or another infection caused the finding
  • Every loose fiber originated in the body
  • A negative examination proves that all symptoms are psychiatric
  • Distress, anxiety, or depression makes physical findings irrelevant

Nor does a visible lesion rule out a coexisting psychiatric condition.

The same evidentiary standard should operate in every direction: examine a physical observation rather than erase it with a psychiatric assumption, and test an interpretation rather than accept it because the observation is emotionally compelling.

How to Document Morgellons Symptoms Without Destroying the Evidence

The goal is not to accumulate the largest possible collection of material. It is to preserve location, chronology, and clinical context.

Four-step guide showing how to photograph a skin finding by recording its location, moving closer, adding a scale, and saving the original image with notes.
Photograph the location, take a closer view, include a scale, and preserve the original files with notes. When medically safe, document a new finding before touching or removing it.

1. Start with a one-page timeline

Record when the problem began, what appeared first, which body areas were affected, whether symptoms recur in the same locations, and what was happening medically around the time of onset. Include new medications, dose changes, illnesses, travel, bites, occupational exposures, and major changes in skin products.

2. Photograph before touching

Take one image showing the body location, one closer image, and one detailed image if your equipment allows it. Include a ruler or scale, use neutral white lighting, and keep the original files. Avoid color filters, AI enhancement, and aggressive sharpening.

3. Record what happened before and after the image

Note washing, ointments, dressings, adhesives, clothing, bedding, scratching, squeezing, or extraction. This information does not discredit the photograph; it allows a clinician to interpret it.

4. Leave one new finding unmanipulated

If medically safe, avoid digging, cutting, scraping, or pulling at a newly symptomatic site before it can be examined. Manipulation can introduce fibers and bacteria, create crust and bleeding, change lesion architecture, and remove the structure whose location matters.

5. Track function as well as appearance

Record pain or itch intensity, sleep disruption, work limitations, and whether a lesion is enlarging, draining, closing, or recurring. These outcomes remain clinically meaningful even when the cause is unresolved.

6. Bring organized information

A concise summary, medication list, prior laboratory and pathology reports, and a small number of clearly labeled photographs are more usable than hundreds of unsorted images or containers. Ask the clinician to document what is observed before debating what it means.

See Find a Morgellons Doctor: How to Prepare and What to Ask and Is There a Morgellons Test? for the next steps.

What a Clinician Can Evaluate

An initial evaluation may include:

  • The morphology, distribution, and stage of the skin lesions
  • Whether a reported filament or plug is visible in place
  • Dermoscopic or magnified examination when appropriate
  • Evidence of infection, inflammation, infestation, or a recognized follicular disorder
  • Medication, supplement, and substance exposures
  • Neurologic or systemic causes of itching, burning, or tingling
  • Sleep, anxiety, depression, cognitive change, and self-injury risk
  • Whether a specifically targeted lesion warrants culture, scraping, or biopsy

When biopsy is clinically appropriate, the target matters. A random sample from nearby skin may miss a small focal structure. A specimen taken after a plug has been removed may lose the architecture needed to determine whether material was superficial, follicular, embedded in crust, or continuous with deeper tissue.

For the limits and possibilities of tissue examination, see Morgellons Histology: What the Skin Really Shows.

When to Seek Urgent Medical Care

Do not wait for a Morgellons specialist when a wound may be infected or another urgent condition is possible.

Seek prompt medical attention for:

  • Redness, warmth, or swelling that is spreading quickly
  • Fever or chills with a skin lesion
  • Severe or rapidly increasing pain, especially pain beyond the visibly affected area
  • Pus, cloudy drainage, a bad odor, or rapidly changing discoloration
  • Red streaks extending from a wound
  • New confusion, shortness of breath, faintness, or signs of severe systemic illness
  • A lesion close to the eye with swelling, vision changes, or severe pain
  • Uncontrolled bleeding or a deep wound

The CDC advises immediate evaluation when a red area spreads quickly or fever or chills accompany suspected cellulitis. Rapidly spreading redness, fever, and severe pain can also signal a rare but life-threatening deep infection.[7][8]

If distress becomes overwhelming or you are thinking about harming yourself, call or text 988 in the United States for immediate crisis support. Call 911 or go to an emergency department when there is immediate danger.[9] Outside the United States, contact your local emergency number or national crisis service.

Frequently Asked Questions

What are the first symptoms of Morgellons?

There is no universal first symptom. In the CDC-supported cohort, sensations were reported first most often, but the sequence varied. See Which usually comes first?

What do Morgellons lesions look like?

Descriptions include papules, erosions, ulcers, crusts, nodules, plug-centered lesions, and scars. See Skin findings and photograph a new lesion before touching it when medically safe.

Where do Morgellons symptoms occur on the body?

Patients report both localized and widespread symptoms. Distribution can help a clinician evaluate follicular disease, contact exposure, neuropathic patterns, and other causes.

Are blue, red, white, or black fibers a Morgellons symptom?

Those colors have been reported, but color alone is uninformative. Location, attachment, scale, tissue relationship, and controlled analysis matter more; see Fibers or filaments associated with skin.

Are black specks proof of Morgellons?

No. “Black speck” describes appearance, not composition. Photograph it in place and include scale and context.

Can Morgellons cause crawling sensations without visible fibers?

Crawling sensations are often reported without a visible surface finding, and they have several possible causes. See Crawling, burning, stinging, and other skin sensations.

Does Morgellons cause fatigue or brain fog?

It has not been established that Morgellons causes fatigue or brain fog. Both appear in published cohorts and require their own clinical evaluation. See Systemic symptoms.

Does having anxiety or depression mean the symptoms are imaginary?

No. Anxiety and depression can coexist with dermatologic, infectious, neurologic, and chronic pain conditions. Their presence neither proves nor disproves the origin of a physical finding.

Can a person have both a physical skin condition and delusional infestation?

Yes. Physical disease, sensory symptoms, mistaken interpretations, and fixed beliefs can coexist and may require parallel care.

Should I remove a plug or fiber to show my doctor?

Avoid self-extraction. A photograph in place and clinician-directed examination usually preserve more useful evidence; see How to document symptoms.

Is there a test that confirms Morgellons from symptoms alone?

No universally accepted symptom score, blood test, biopsy result, or fiber test confirms Morgellons. See Is There a Morgellons Test?.

The Bottom Line

Morgellons symptoms should be taken seriously without being treated as self-interpreting.

The most characteristic presentation includes reported fibers or other material together with skin lesions and/or disturbing cutaneous sensations. Published cohorts also document fatigue, musculoskeletal symptoms, sleep disruption, cognitive complaints, and substantial effects on quality of life. Yet no individual symptom—or collection of nonspecific systemic symptoms—establishes a Morgellons diagnosis or identifies its cause.

The productive path is to preserve the least-altered finding, distinguish symptoms from observable signs, examine ordinary differential diagnoses, and measure the effects on health and daily function. Investigation should neither begin with automatic dismissal nor end with the patient’s first explanation.

Help Build Better Evidence

If you have, or believe you have, Morgellons, your experience can help identify patterns that isolated case reports cannot. The Morgellons Survey collects patient-reported information about symptoms, history, and lived experience.

Take the Morgellons Survey

Please participate only once. Survey responses describe patient experience; they do not provide a diagnosis or replace medical care.

Continue Reading

Sources

1. Akbarialiabad H, Salehi S, Murrell DF, Jafferany M. Morgellons disease: a review on current evidence and the need for consensus, standardized criteria, and future randomized controlled trials. Archives of Dermatological Research. 2025;317:815. https://doi.org/10.1007/s00403-025-04308-6

2. Pearson ML, Selby JV, Katz KA, et al. Clinical, epidemiologic, histopathologic, and molecular features of an unexplained dermopathy. PLOS ONE. 2012;7(1):e29908. https://doi.org/10.1371/journal.pone.0029908

3. Middelveen MJ, Mayne PJ, Kahn DG, Stricker RB. Characterization and evolution of dermal filaments from patients with Morgellons disease. Clinical, Cosmetic and Investigational Dermatology. 2013;6:1–21. https://doi.org/10.2147/CCID.S39017

4. Middelveen MJ, Fesler MC, Stricker RB. History of Morgellons disease: from delusion to definition. Clinical, Cosmetic and Investigational Dermatology. 2018;11:71–90. https://doi.org/10.2147/CCID.S152343

5. Gipple MO, Dhami RK, Latour E, Keller JJ. Patients with Morgellons disease have a lower quality of life than patients with psoriasis, atopic dermatitis, and prurigo nodularis. British Journal of Dermatology. 2025;192(1):163–165. https://doi.org/10.1093/bjd/ljae335

6. Fesler MC, Middelveen MJ, Stricker RB. Clinical evaluation of Morgellons disease in a cohort of North American patients. Dermatology Reports. 2018;10(1):7660. https://doi.org/10.4081/dr.2018.7660

7. Centers for Disease Control and Prevention. About Cellulitis. Updated August 5, 2025. https://www.cdc.gov/group-a-strep/about/cellulitis.html

8. Centers for Disease Control and Prevention. About Necrotizing Fasciitis. Updated May 15, 2024. https://www.cdc.gov/group-a-strep/about/necrotizing-fasciitis.html

9. 988 Suicide & Crisis Lifeline. Get Help. https://988lifeline.org/


Medical disclaimer: This page provides educational information and methodological commentary. It does not diagnose Morgellons or any other condition and is not a substitute for medical advice, examination, or treatment from a licensed healthcare professional.